Toll-like receptor agonists regulate β-defensin 2 release in hair follicle

被引:16
|
作者
Selleri, S.
Arnaboldi, F.
Palazzo, M.
Gariboldi, S.
Zanobbio, L.
Opizzi, E.
Shirai, Y. F.
Balsari, A.
Rumio, C.
机构
[1] Univ Milan, Dept Human Morphol, I-20133 Milan, Italy
[2] Univ Milan, Inst Pathol, I-20133 Milan, Italy
[3] Ist Nazl Tumori, Mol Target Unit, I-20133 Milan, Italy
关键词
beta-defensin; 2; hair follicle; mouse; skin; toll-like receptor;
D O I
10.1111/j.1365-2133.2007.07899.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Skin is constantly in contact with different pathogens, which are present in the environment. The hair follicle is particularly susceptible to this microbial invasion as it offers an easy way of access for microorganisms; for this reason it is equipped with defence mechanisms to avoid frequent infections. Objectives To analyse the expression pattern of four different members of the toll-like receptor (TLR) family in murine hair follicles and to evaluate the effects of their activation by their specific microbiota-derived agonists, in terms of production of the antimicrobial peptide beta-defensin 2 (DEFB2). Methods TLR and DEFB2 protein expression was investigated by immunohistochemistry on murine skin samples. Results Murine hair follicle expresses TLR2, TLR4 and TLR5; agonists of TLR2, TLR4 and TLR5 but not of TLR9 induced DEFB2 production in this compartment. The strongest DEFB2 expression was observed following TLR4 activation by lipopolysaccharide. Conclusions Our data show that the hair follicle is equipped with TLR2, TLR4 and TLR5, and that these receptors are able to respond to microbial stimuli inducing the production of DEFB2 by epithelial cells. This immune response might be important in preserving the skin from microorganism infections.
引用
收藏
页码:1172 / 1177
页数:6
相关论文
共 50 条
  • [41] The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
    Huang, Lingling
    Ge, Xiaoyan
    Liu, Yang
    Li, Hui
    Zhang, Zhiyue
    PHARMACEUTICS, 2022, 14 (06)
  • [42] Toll-like receptor agonists targeted to cancer cell metabolism
    Mancini, Rock
    Nielsen, Amy
    Hantho, Joseph
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [43] Trial Watch: Toll-like receptor agonists in cancer immunotherapy
    Smith, Melody
    Garcia-Martinez, Elena
    Pitter, Michael R.
    Fucikova, Jitka
    Spisek, Radek
    Zitvogel, Laurence
    Kroemer, Guido
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2018, 7 (12):
  • [44] Activation of airway epithelial cells by toll-like receptor agonists
    Sha, Q
    Truong-Tran, AQ
    Plitt, JR
    Beck, LA
    Schleimer, RP
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 31 (03) : 358 - 364
  • [45] Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia
    Spaner, D. E.
    Masellis, A.
    LEUKEMIA, 2007, 21 (01) : 53 - 60
  • [46] Facile syntheses of functionalized toll-like receptor 7 agonists
    Akinbobuyi, Babatope
    Byrd, Matthew R.
    Chang, Charles A.
    Nguyen, Mysa
    Seifert, Zacharie J.
    Flamar, Anne-Laure
    Zurawski, Gerard
    Upchurch, Katherine C.
    Oh, SangKon
    Dempsey, Stephen H.
    Enke, Thomas J.
    Le, John
    Winstead, Hunter J.
    Boquin, Jose R.
    Kane, Robert R.
    TETRAHEDRON LETTERS, 2015, 56 (02) : 458 - 460
  • [47] Toll-like receptor agonists: New opportunities for drug development
    Wagner, Hermann
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (01): : 58 - 58
  • [48] Clinical setbacks for toll-like receptor 9 agonists in cancer
    Schmidt, Charlie
    NATURE BIOTECHNOLOGY, 2007, 25 (08) : 825 - 826
  • [49] Trial Watch Toll-like receptor agonists for cancer therapy
    Vacchelli, Erika
    Eggermont, Alexander
    Sautes-Fridman, Catherine
    Galon, Jerome
    Zitvogel, Laurence
    Kroemer, Guido
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2013, 2 (08):
  • [50] Aerosolized Toll-like Receptor Agonists Suppress Allergic Inflammation
    Goldblatt, David
    Fouts, Adrienne
    Wali, Shradha M.
    Valverde-Ha, Gabriella
    Moczygemba-Martinez, Margarita
    Huston, David P.
    Tuvim, Michael J.
    Dickey, Burton
    Evans, Scott
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):